Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05337826 · ClinicalTrials.gov registry record · NA
The REST Study for CGM Use in Older Adults With Insulin-treated Diabetes
A NA study of Diabetes Mellitus, sponsored by Joslin Diabetes Center.
- Active
- Registry status
- NA
- Development phase
- 122
- Enrollment target
- 2
- Study locations
NCT05337826 is a NA study of Diabetes Mellitus that is active but no longer recruiting, run by Joslin Diabetes Center. The registered enrollment target is 122 participants, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (93% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT05337826, a NA study of Diabetes Mellitus, is active but no longer recruiting, sponsored by Joslin Diabetes Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 122 participants
- Enrollment target
- 2
- Study locations
Study Summary
To assess the efficacy of the REST model in facilitating adoption and sustained use of CGM, in older adults with Type 1 diabetes (T1D) or Type 2 Diabetes (T2D) on complex insulin regimens. To examine barriers and enablers for the implementation feasibility of the REST intervention model using a mixed-methods approach. To assess the impact of REST model on economic factors and quality of life measures. The goal of this study is to facilitate the adoption of continuous glucose monitoring (CGM) in older adults (≥65 years) with diabetes mellitus (DM) on complex insulin regimens, and additionally, to build a framework for sustained CGM use over time using a novel patient-centered model - the REST model.
Conditions Studied
Interventions
- DEVICE Continuous Glucose Monitor
Study Locations (2)
Massachusetts
- Joslin Diabetes Center - Boston
New York
- SUNY Upstate Medical University - Syracuse
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 122 participants |
| Start Date | 2022-04-20 |
| Est. Completion | 2026-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05337826
The ClinicalTrials.gov registry entry for NCT05337826 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 122 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (93% lower). The listed sponsor is Joslin Diabetes Center, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which Continuous Glucose Monitor is the first listed.
NCT05337826 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Massachusetts, New York.
Frequently Asked Questions
What is clinical trial NCT05337826 about?
NCT05337826 is a clinical study titled "The REST Study for CGM Use in Older Adults With Insulin-treated Diabetes". To assess the efficacy of the REST model in facilitating adoption and sustained use of CGM, in older adults with Type 1 diabetes (T1D) or Type 2 Diabetes (T2D) on complex insulin regimens. To examine barriers and enablers for the implementation feasibility of the REST intervention model using a mixe...
What is the current status of trial NCT05337826?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 122 participants. The study started on 2022-04-20. Estimated completion is 2026-05.
What conditions does trial NCT05337826 study?
This clinical trial studies the following conditions: Diabetes Mellitus.
What interventions are being tested in trial NCT05337826?
The interventions under investigation include: Continuous Glucose Monitor (DEVICE).
Who is sponsoring clinical trial NCT05337826?
This trial is sponsored by Joslin Diabetes Center, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05337826 being conducted?
This trial has 2 study locations across Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Improving Glycemic Control With Telemedicine and Smart Insulin Pens
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility
RECRUITING · NA
-
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
RECRUITING · NA
-
Innovative Multi-Variable Biofeedback for Improving Gait Performance in Individuals With Diabetic Peripheral Neuropathy
RECRUITING · NA
-
Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.